Casting Versus Flexible Intramedullary Nailing in Displaced Pediatric Forearm Shaft Fractures

Sponsor
Helsinki University Central Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04664517
Collaborator
(none)
90
5
4
44
18
0.4

Study Details

Study Description

Brief Summary

The forearm is the most common fracture location in children, with an increasing incidence. Displaced forearm shaft fractures have traditionally been treated with closed reduction and cast immobilization. Diaphyseal fractures in children have poor remodeling capacity, and malunion can thus cause permanent cosmetic and functional disability. Internal fixation especially with flexible intramedullary nails has gained increasing popularity, without evidence of a better outcome compared to closed reduction and cast immobilization.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Flexible intramedullary nail (FIN)
  • Procedure: Reduction auder general anesthesia and long arm cast
N/A

Detailed Description

This is a multicenter, randomized superiority trial comparing closed reduction and cast immobilization to flexible intramedullary nails in 7-12 year old children with > 10° of angulation and/or > 10mm of shortening in displaced both bone forearm shaft fractures (AO-pediatric classification: 22D/2.1-5.2). A total of 78 patients with minimum 2 years of expected growth left are randomized in 1:1 ratio to either treatment group. The study has a parallel non-randomized patient preference arm. Both treatments are performed under general anesthesia. In the cast group a long arm cast is applied for 6 weeks. The flexible intramedullary nail group is immobilized in a collar and cuff sling for 4 weeks. Data is collected at baseline and at each follow-up until 1 year.

Primary outcome is 1) PROMIS Pediatric Item Bank v2.0 - Upper Extremity and 2) forearm pronation-supination range of motion at one-year follow-up. Secondary outcomes are Quick DASH, Pediatric pain questionnaire, Cosmetic VAS, wrist range of motion as well as any complications (malunion, delayed union, non-union or deep wound infection, peripheral nerve injury, need for re-intervention during 1-year follow-up) and costs of treatment.

The investigators hypothesize that flexible intramedullary nailing results in a superior outcome.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
multicenter, randomized superiority trial. Parallell patient choice arm.multicenter, randomized superiority trial. Parallell patient choice arm.
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Casting Versus Flexible Intramedullary Nailing in Displaced Forearm Shaft Fractures in 7 to 12 Years Old Children: A Study Protocol for a Randomized Controlled Trial
Actual Study Start Date :
May 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: FIN (Flexible intramedullary nail)

Fracture reduction and fixation using flexible intramedullary nails. Nails size is 0.4 times the smallest diameter of the medullary canal of radius or ulna measured in radiographs.

Procedure: Flexible intramedullary nail (FIN)
Both bone FIN

Active Comparator: Long arm cast

Fractures are reduced under general anesthesia within 3 days from injury and a synthetic circular above elbow cast in neutral pro-supination is applied for six weeks.

Procedure: Reduction auder general anesthesia and long arm cast
Reduction and cast

Other: Patient Choice FIN

Fracture reduction and fixation using flexible intramedullary nails. Nails size is 0.4 times the smallest diameter of the medullary canal of radius or ulna measured in radiographs.

Procedure: Flexible intramedullary nail (FIN)
Both bone FIN

Other: Patient Choice cast

Fractures are reduced under general anesthesia within 3 days from injury and a synthetic circular above elbow cast in neutral pro-supination is applied for six weeks.

Procedure: Reduction auder general anesthesia and long arm cast
Reduction and cast

Outcome Measures

Primary Outcome Measures

  1. PROMIS Pediatric Item Bank v2.0 - Upper Extremity [12 months]

    We aim to confirm that 75 percent of FIN patients have a better PROMIS UE score than what the mean score of the cast patients will be assuming both groups have the same standard deviation. PROMIS (Patient-Reported Outcomes Measurement Information System) scores are normalized to a mean score of 50, standard deviation of 10, with a theoretical range of 0 to 100. A higher score corresponds to a greater amount of the domain being measured.

  2. Pro-supination [12 months]

    Difference (percent) in forearm pronation-supination range of motion (ROM) at one-year follow-up in comparison to uninjured side.

Secondary Outcome Measures

  1. Quick Disabilities of the Arm, Shoulder and Hand score [6 weeks, 3, 6 and 12 months]

    Minimum value is 0 and maximum 100. Higher value indicates worse function. Statistically significant difference in QuickDASH score is 6.8 (18) at 12 months FU.

  2. Measurement Model for the Pediatric Quality of Life Inventory (PedsQL) [6 weeks, 3, 6 and 12 months]

    Minimum value is 0 and maximum value is 100. Higher score indicates better health related quality of life.

  3. Measurement Model for the Pediatric Quality of Life Inventory Pediatric Pain Questionaire (PEDS QL PPQ) [6 weeks, 3, 6 and 12 months]

    Minimum value 0 maximum value 10. Higher value indicates higher pain intensity

  4. Need for re-interventions [6 weeks, 3, 6 and 12 months]

    Minimum value 0 no maximum value. Lower value indicates better outcome.

  5. Rate of participants with malunion [6 weeks, 3, 6 and 12 months]

    malunion, delayed union (defined as nonunion at 3 months or later), pseudoarthrosis (defined as 3 cortices out of 4 not united at 6 months or later)

  6. Adverse effects [6 weeks, 3, 6 and 12 months]

    adverse effects (wound infection, nerve or/and tendon damage)

  7. Cosmetic VAS [6 weeks, 3, 6 and 12 months]

    Minimum value 0 maximum value 10. Higher value indicates better satisfaction

  8. PROMIS Pediatric Item Bank v2.0 - Upper Extremity [6 weeks, 3, 6 months]

    Difference between treatment groups

  9. Upper limb ROM [6 weeks, 3, 6 months]

    Difference (percent) in elbow, wrist flexion extension and pronation-supination in comparison to uninjured side

  10. Return to sport/musical instrument and level [6 weeks, 3, 6 and 12 months]

    Level of practiced sport or musical instrument before and at end of trial, as well as time from injury to return to hobby is registered.

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 7 to12 year old children

  • Open distal radial physis

  • Both bone forearm shaft fractures (AO-pediatric classification: 22D/2.1-5.2)

  • More than 10 degrees of angulation

  • with or without less than 10mm of shortening

Exclusion Criteria:
  • Patients with bilateral fractures

  • Gustilo-Anderson grade I-III open fracture

  • Neurovascular deficit

  • Compartment syndrome

  • Pathologic fracture

  • Patient not able to give a written informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 HUS New Childrens Hospital Helsinki Finland 00029HUS
2 Kuopio University Hospital Kuopio Finland
3 Oulu University Hospital Oulu Finland
4 Tampere University Hospital Tampere Finland
5 Turku University Hospital Turku Finland

Sponsors and Collaborators

  • Helsinki University Central Hospital

Investigators

  • Study Director: Ilkka Helenius, MD, Helsinki University Central Hospital
  • Principal Investigator: Petra Grahn, MD, Helsinki University Central Hospital

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Petra Grahn, Hand Surgeon, Principal investigator, Helsinki University Central Hospital
ClinicalTrials.gov Identifier:
NCT04664517
Other Study ID Numbers:
  • 78/1801/2020
First Posted:
Dec 11, 2020
Last Update Posted:
Jul 30, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 30, 2021